Dividend Stocks Worth Watching - April 29th

ProShares UltraPro Short QQQ, Direxion Daily TSLA Bull 2X Shares, and Pfizer are the three Dividend stocks to watch today, according to MarketBeat's stock screener tool. Dividend stocks are equity shares of companies that regularly distribute a portion of their profits to shareholders as cash payments, known as dividends. These stocks appeal to investors seeking a steady income stream and can also offer capital appreciation if the share price rises. Firms that pay dividends tend to be mature, cash-generating businesses with stable earnings. These companies had the highest dollar trading volume of any Dividend stocks within the last several days.

ProShares UltraPro Short QQQ (SQQQ)

ProShares UltraPro Short QQQ (the Fund) seeks daily investment results, which corresponds to three times the inverse of the daily performance of the NASDAQ-100 Index (the Index). The Index includes 100 of the non-financial domestic and international issues listed on National Association of Securities Dealers Automated Quotation (NASDAQ) Stock Market.

ProShares UltraPro Short QQQ stock traded down $0.66 during midday trading on Tuesday, reaching $31.03. 74,894,419 shares of the company were exchanged, compared to its average volume of 49,957,882. The firm's 50-day simple moving average is $36.65 and its 200-day simple moving average is $33.15. ProShares UltraPro Short QQQ has a 1 year low of $26.21 and a 1 year high of $61.60.

Read Our Latest Research Report on SQQQ

Direxion Daily TSLA Bull 2X Shares (TSLL)

NASDAQ TSLL traded up $0.02 during mid-day trading on Tuesday, reaching $10.56. 154,943,876 shares of the stock were exchanged, compared to its average volume of 84,963,745. The stock has a market capitalization of $5.47 billion, a PE ratio of 48.19 and a beta of -5.14. Direxion Daily TSLA Bull 2X Shares has a 1-year low of $6.29 and a 1-year high of $41.50. The business's fifty day simple moving average is $10.06 and its 200 day simple moving average is $18.33.

Read Our Latest Research Report on TSLL

Pfizer (PFE)

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands.

Pfizer stock traded up $0.93 during trading on Tuesday, hitting $23.98. The company's stock had a trading volume of 66,753,387 shares, compared to its average volume of 40,701,218. The stock's fifty day moving average is $24.52 and its 200 day moving average is $25.88. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.73 and a current ratio of 1.00. Pfizer has a 1-year low of $20.92 and a 1-year high of $31.54. The stock has a market capitalization of $135.97 billion, a price-to-earnings ratio of 16.99, a P/E/G ratio of 0.64 and a beta of 0.67.

Read Our Latest Research Report on PFE